سعر توجيو سولوستار Toujeo solostar 300 وحدة دولية /مل 1.5مل 5 اقلام 2026
Toujeo solostar 300 i.u./ml 1.5 ml 5 pensدواعي استعمال توجيو سولوستار
- To improve glycemic control in adults and pediatric patients 6 years and older with diabetes mellitusالفئة: Adults and children >=6 yearsDailyMed (U.S. National Library of Medicine)
- To improve glycemic control in adults and pediatric patients 6 years and older with diabetes mellitusPopulation: Adults and children >=6 yearsDailyMed (U.S. National Library of Medicine)
معلومات الدواء
التفاصيل الكاملةالآثار الجانبيةSide effects
- Common (>=5%): hypoglycaemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, oedema and weight gain.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Common (>=5%): hypoglycaemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, oedema and weight gain.International label, same product · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
- During episodes of hypoglycaemia.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Hypersensitivity to insulin glargine or any excipient.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- During episodes of hypoglycaemia.International label, same product · DailyMed (U.S. National Library of Medicine)
- Hypersensitivity to insulin glargine or any excipient.International label, same product · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطاتWarnings & precautions
- Changes in insulin regimen (strength, manufacturer, type, site or method) may cause hyper- or hypoglycaemia; make changes under close medical supervision.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Hypoglycaemia may be life-threatening; medication errors from insulin mix-ups can occur, so check insulin labels before each injection.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Severe generalized allergy including anaphylaxis can occur.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Changes in insulin regimen (strength, manufacturer, type, site or method) may cause hyper- or hypoglycaemia; make changes under close medical supervision.International label, same product · DailyMed (U.S. National Library of Medicine)
- Hypoglycaemia may be life-threatening; medication errors from insulin mix-ups can occur, so check insulin labels before each injection.International label, same product · DailyMed (U.S. National Library of Medicine)
- Severe generalized allergy including anaphylaxis can occur.International label, same product · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائيةDrug interactions
- Antidiabetic agents, ACE inhibitors, ARBs, fibrates, fluoxetine, MAOIs, salicylates, sulfonamides, GLP-1 agonists, DPP-4 and SGLT-2 inhibitorsMay increase hypoglycaemia risk; dose reduction and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)
- Atypical antipsychotics, corticosteroids, diuretics, estrogens/progestogens, isoniazid, niacin, somatropin, sympathomimetics, thyroid hormonesMay decrease the glucose-lowering effect; dose increase and more frequent monitoring may be required.DailyMed (U.S. National Library of Medicine)
- Alcohol, beta-blockers, clonidine, lithium, pentamidineMay increase or decrease the glucose-lowering effect; beta-blockers and clonidine may blunt signs of hypoglycaemia.DailyMed (U.S. National Library of Medicine)
- Antidiabetic agents, ACE inhibitors, ARBs, fibrates, fluoxetine, MAOIs, salicylates, sulfonamides, GLP-1 agonists, DPP-4 and SGLT-2 inhibitorsMay increase hypoglycaemia risk; dose reduction and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)
- Atypical antipsychotics, corticosteroids, diuretics, estrogens/progestogens, isoniazid, niacin, somatropin, sympathomimetics, thyroid hormonesMay decrease the glucose-lowering effect; dose increase and more frequent monitoring may be required.DailyMed (U.S. National Library of Medicine)
- Alcohol, beta-blockers, clonidine, lithium, pentamidineMay increase or decrease the glucose-lowering effect; beta-blockers and clonidine may blunt signs of hypoglycaemia.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعةPregnancy & breastfeeding
- Published studies have not reported a clear association between insulin glargine and adverse developmental outcomes; poorly controlled diabetes carries maternal and fetal risks.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- No or limited data on insulin glargine in human milk; endogenous insulin is present in milk. Weigh benefits of breastfeeding against maternal need.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Published studies have not reported a clear association between insulin glargine and adverse developmental outcomes; poorly controlled diabetes carries maternal and fetal risks.International label, same product · DailyMed (U.S. National Library of Medicine)
- No or limited data on insulin glargine in human milk; endogenous insulin is present in milk. Weigh benefits of breastfeeding against maternal need.International label, same product · DailyMed (U.S. National Library of Medicine)
كيف يعمل الدواءHow it works
- إنسولين جلارجين: Lowers blood glucose by stimulating peripheral glucose uptake (skeletal muscle, fat) and inhibiting hepatic glucose production; inhibits lipolysis and proteolysis (US label).
- Insulin glargine: Lowers blood glucose by stimulating peripheral glucose uptake (skeletal muscle, fat) and inhibiting hepatic glucose production; inhibits lipolysis and proteolysis (US label).
تابع أسعار الأدوية أول بأول
بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص
المثائل (1)
كل المثائل والبدائلنفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.
| الدواء | السعر | الفرق عن الأصلي |
|---|---|---|
| توجيو سولوستار 300وحدة/مل 1.5مل 3 اقلامToujeo solostar 300 i.u./ml 1.5 ml 3 pensSanofi · 300 units/mlالأرخص | السعر1,416ج.م472ج.م للوحدة | الفرق عن الأصليأرخص 944ج.م (40%) |
تاريخ السعر
تغيّر السعر الرسمي: من 1,320 إلى 2,360 ج.م، 2 أسعار مسجلة
| التاريخ | السعر (ج.م) |
|---|---|
| سعر سابق بدون تاريخ | 1,320 |
| 2,360 |
| التاريخ | من | إلى | التغيير |
|---|---|---|---|
| 1,320ج.م | 2,360ج.م | زيادة 78.8% |
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Sanofi
من فئة مضاد للسكري
- Abasaglar 100 I.U./ml 5 Cartridgesمحلول للحقن في خرطوشة645ج.م
- Abasaglar Kwikpen 100 I.U./ml 5 Pensمحلول للحقن في قلم معبأ مسبقاً725ج.م
- ACTRAPID HM 100 I.U./ML 5*3ML PENFILLSمحلول للحقن في خرطوشة (بنفيل)338ج.م
- Alexodiab 1000mg 30 tabsأقراص13.5ج.م
- Alexodiab 500 mg 30 tabsأقراص12ج.م
- اماجلوست 2/30مجم 30 قرصأقراص مقسمة93ج.م
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (U.S. National Library of Medicine)
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا